¥336.65
Above FV▼ -51.4% against the close used
Model range ¥10.86 – ¥659.59
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear¥10.86Fair value¥336.65Bull¥659.59
FairClose
52-week traded range
52W low ¥521.0052W high ¥878.00
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Pharma Foods International Co.,Ltd. closed at ¥692.00, 105.6% above the consensus fair value of ¥336.65 drawn from 9 valuation models.
Financial DNA score 32/100 — Weak. P/E of 53.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
¥240.47
-65.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥339.81
-50.9%
√(22.5 × EPS × BVPS)
EPS=12.83, BVPS=400 · outside Graham range (P/E 53.9, P/B 1.7) — asset-light, treat as a rough floor
P/E Fair Value
¥256.60
-62.9%
EPS × 20x (sector P/E)
EPS=12.83, Sector P/E=20x
Peter Lynch (PEG)
¥384.90
-44.4%
EPS × Growth% (PEG = 1 is fair)
EPS=12.83, g=30%
EV/EBITDA
¥659.59
-4.7%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=3.1B
Dividend Discount (DDM)
¥318.51
-54.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=24.98, r=10%, g=2%
Book Value (P/B)
¥10.86
-98.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=400, ROE=3.2%, g=3%, r=10%
Reverse DCF
¥692.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 20.6% | Historical: -44.4%
Margin of Safety
¥209.22
-69.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=278.96, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.